TEAD4 and cancer: For example, TEAD4-S disrupts the binding of canonical TEAD4-FL to YAP by virtue of the performance of dominant-negative isoform, so as to repress cancer cell proliferation and epithelial-to-mesenchymal transition (EMT) [13].